Specifically, phosphorylation of S111 influences the promotion of the epithelial-mesenchymal transition (EMT), and this specific PTM is known to decrease the repressive activity of LSD1, which is associated with breast cancer stem cell development. The gene discussed is KDM1A; the disease is breast carcinoma.